<rss version="2.0" xmlns:a10="http://www.w3.org/2005/Atom"><channel><title>RSC - RSC Med. Chem. latest articles</title><link>http://pubs.rsc.org/en/Journals/Journal/MD</link><description>RSC - RSC Med. Chem. latest articles</description><copyright>Copyright (c)  The Royal Society of Chemistry</copyright><lastBuildDate>Tue, 30 Jun 2026 11:26:23 Z</lastBuildDate><category>RSC - RSC Med. Chem. latest articles</category><image><url>http://pubs.rsc.org/content/NewImages/rsc_publishing_logo.gif</url><title>RSC - RSC Med. Chem. latest articles</title><link>http://pubs.rsc.org/en/Journals/Journal/MD</link></image><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00183A"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00183A</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00183A</link><title>Inhibition effects and binding behavior of alginate oligosaccharides on tyrosinase and elastase: multi-spectroscopic approaches and zebrafish evaluation</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00183A" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00183A, Research Article&lt;/div&gt;&lt;div&gt;Hangen Li, Shuyi Liang, Yuanyi Cen, Yan Liang, Xuetao Xu&lt;br/&gt;(1) AOSs were inhibitors on tyrosinase and elastase. Multi-spectroscopic and docking approaches revealed inhibition interaction of AOSs on tyrosinase and elastase. (2) AOSs displayed the ability of melanin inhibition and ROS clearance.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-06-29T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Hangen Li</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Shuyi Liang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yuanyi Cen</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yan Liang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Xuetao Xu</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00312E"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00312E</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00312E</link><title>Design, synthesis, and X-ray structural studies of potent SARS-CoV-2 Mpro inhibitors containing tetrahydroisoquinoline-3-carboxamides as P2 ligands</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00312E" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00312E, Research Article&lt;/div&gt;&lt;div&gt;&lt;img  alt='Open Access' src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png' /&gt; Open Access&lt;/div&gt;&lt;div&gt;&lt;a rel='license' href='http://creativecommons.org/licenses/by-nc/3.0/' target='_blank' title='This link will open in a new browser window'&gt; &lt;img src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY-NC.png' alt='Creative Commons Licence' border='none'/&gt;&lt;/a&gt;&amp;nbsp This article is licensed under a &lt;a text-decoration=none rel='license' href='http://creativecommons.org/licenses/by-nc/3.0/' target='_blank' title='This link will open in a new browser window' &gt;Creative Commons Attribution-NonCommercial 3.0 Unported Licence.&lt;/a&gt;&lt;/div&gt;&lt;div&gt;Arun K. Ghosh, Ashish Sharma, Satyanarayana Iddum, Sydney N. Bogan, Uttara Jayashankar, Emma K. Lendy, Shin-ichiro Hattori, Nobuyo Higashi-Kuwata, Hiroaki Mitsuya, Andrew D. Mesecar&lt;br/&gt;A series of potent SARS-CoV-2 Mpro inhibitors is designed, synthesized and evaluated. Inhibitor &lt;strong&gt;5j&lt;/strong&gt; and the X-ray structure of the SARS-CoV-2 Mpro–&lt;strong&gt;5j&lt;/strong&gt; complex are represented.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-06-29T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Arun K. Ghosh</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Ashish Sharma</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Satyanarayana Iddum</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Sydney N. Bogan</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Uttara Jayashankar</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Emma K. Lendy</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Shin-ichiro Hattori</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Nobuyo Higashi-Kuwata</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Hiroaki Mitsuya</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Andrew D. Mesecar</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00278A"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00278A</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00278A</link><title>Synthesis, molecular modelling and evaluation of (−)-isopulegol-based 2,4-diaminopyrimidines as promising aurora kinase inhibitors</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00278A" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00278A, Research Article&lt;/div&gt;&lt;div&gt;&lt;img  alt='Open Access' src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png' /&gt; Open Access&lt;/div&gt;&lt;div&gt;&lt;a rel='license' href='http://creativecommons.org/licenses/by-nc/3.0/' target='_blank' title='This link will open in a new browser window'&gt; &lt;img src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY-NC.png' alt='Creative Commons Licence' border='none'/&gt;&lt;/a&gt;&amp;nbsp This article is licensed under a &lt;a text-decoration=none rel='license' href='http://creativecommons.org/licenses/by-nc/3.0/' target='_blank' title='This link will open in a new browser window' &gt;Creative Commons Attribution-NonCommercial 3.0 Unported Licence.&lt;/a&gt;&lt;/div&gt;&lt;div&gt;Tam Minh Le, Nikoletta Szemerédi, Gabriella Spengler, Minh Canh Nguyen, Huynh Nguyen Khanh Tran, Khac-Minh Thai, Zsolt Szakonyi&lt;br/&gt;(−)-Isopulegol-based 2,4-diaminopyrimidines were prepared and evaluated for cytotoxicity against human colon adenocarcinoma cell lines. Molecular docking analysis indicated their interaction with the aurora kinase A receptor.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-06-03T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Tam Minh Le</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Nikoletta Szemerédi</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Gabriella Spengler</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Minh Canh Nguyen</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Huynh Nguyen Khanh Tran</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Khac-Minh Thai</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Zsolt Szakonyi</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00382F"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00382F</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00382F</link><title>Ring-Opening Simplification of Thiazolyl-Pyrazoline-Triazole Hybrids: Synthesis, SAR and Antifolate Mechanism Against Leishmania major</title><description>&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Accepted Manuscript&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00382F, Research Article&lt;/div&gt;&lt;div&gt;Esraa A Abdelsalam, Wagdy M. Eldehna, Radwan  El-Haggar, Sherif Hammad, Nicolas MASURIER, Tamer M Ibrahim, Kikuko Amagase, Sherry N Nasralla, Hatem A. Abdel-Aziz, Adnan Bekhit&lt;br/&gt;Leishmaniasis, a neglected tropical disease with a severely limited and toxicity-prone therapeutic arsenal, urgently demands structurally innovative drug candidates. Capitalizing on the well-established antileishmanial potential of thiazole, triazole, and pyrazole...&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-06-27T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Esraa A Abdelsalam</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Wagdy M. Eldehna</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Radwan  El-Haggar</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Sherif Hammad</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Nicolas MASURIER</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Tamer M Ibrahim</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Kikuko Amagase</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Sherry N Nasralla</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Hatem A. Abdel-Aziz</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Adnan Bekhit</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00403B"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00403B</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00403B</link><title>Drug Repurposing of Fluvastatin as a DP2 Antagonist: An Ensemble Learning Strategy with In Vitro Cellular Functional Validation</title><description>&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Accepted Manuscript&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00403B, Research Article&lt;/div&gt;&lt;div&gt;GuoHui Wei, Zhuo  Sun, Yuanxu  Gao, Jia  Heng, Wenyang  Lu, Zixing  Zou&lt;br/&gt;We present a framework to repurpose FDA-approved drugs as DP2 antagonists for asthma, using a two-stage strategy. First, we train and evaluate eight models—five machine learning algorithms and three graph...&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-06-24T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">GuoHui Wei</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Zhuo  Sun</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yuanxu  Gao</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Jia  Heng</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Wenyang  Lu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Zixing  Zou</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00112B"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00112B</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00112B</link><title>From dual norepinephrine-dopamine reuptake inhibition to selective dopamine reuptake inhibitors: a case of aromatically substituted N,2-cyclopentylamines</title><description>&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Accepted Manuscript&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00112B, Research Article&lt;/div&gt;&lt;div&gt;&lt;img  alt='Open Access' src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png' /&gt; Open Access&lt;/div&gt;&lt;div&gt;&lt;a rel='license' href='http://creativecommons.org/licenses/by/3.0/' target='_blank' title='This link will open in a new browser window'&gt; &lt;img src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY.png' alt='Creative Commons Licence' border='none' /&gt;&lt;/a&gt;&amp;nbsp This article is licensed under a &lt;a text-decoration=none rel='license' href='http://creativecommons.org/licenses/by/3.0/' target='_blank' title='This link will open in a new browser window' &gt;Creative Commons Attribution 3.0 Unported Licence.&lt;/a&gt;&lt;/div&gt;&lt;div&gt;Majlen A. Dilweg, Willem Jespers, Ameya S Kasture, Rongfang Liu, Tamara A. M. Mocking, Jelle G Van Der Ploeg, M M Baselier, Gerard Van Westen, Thomas  Hummel, Sonja  Sucic, Adriaan P. IJzerman, Laura H. Heitman, Daan van der Es&lt;br/&gt;Dopamine (DA) is essential for motor control, mood, motivation, and reward in the central nervous system. It functions through receptor activation and is regulated by the dopamine transporter (DAT, SLC6A3),...&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-06-24T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Majlen A. Dilweg</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Willem Jespers</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Ameya S Kasture</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Rongfang Liu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Tamara A. M. Mocking</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Jelle G Van Der Ploeg</creator><creator xmlns="http://purl.org/dc/elements/1.1/">M M Baselier</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Gerard Van Westen</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Thomas  Hummel</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Sonja  Sucic</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Adriaan P. IJzerman</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Laura H. Heitman</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Daan van der Es</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00250A"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00250A</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00250A</link><title>Combining β2-AR agonism with butyrylcholinesterase inhibition, a synergistic neuroprotective action against Alzheimer's disease</title><description>&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Accepted Manuscript&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00250A, Research Article&lt;/div&gt;&lt;div&gt;Alice  Wang, Thomas  Curel, Sylvie Claeysen, Valentin  Travers-Lesage, Marie Elodie Hélène Cadot, Audrey Davis, Jana Sopkova de Oliveira Santos, Fabrice  Modeste, Xavier Brazzolotto, Florian Nachon, Patrick Dallemagne, Marc Since, Christophe Rochais&lt;br/&gt;Alzheimer’s disease (AD) is a multifactorial neurodegenerative disorder for which the current treatments remain largely symptomatic. Pleiotropic prodrug strategies offer a promising approach to address this complexity, combining complementary pharmacological...&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-06-24T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Alice  Wang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Thomas  Curel</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Sylvie Claeysen</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Valentin  Travers-Lesage</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Marie Elodie Hélène Cadot</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Audrey Davis</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Jana Sopkova de Oliveira Santos</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Fabrice  Modeste</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Xavier Brazzolotto</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Florian Nachon</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Patrick Dallemagne</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Marc Since</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Christophe Rochais</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00418K"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00418K</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00418K</link><title>Exploring the Antimycobacterial Profile of N-Alkyl Imidazoles</title><description>&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Accepted Manuscript&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00418K, Research Article&lt;/div&gt;&lt;div&gt;Alejandro I. Recio-Balsells, Gabriel Di Gresia, Marcelo Luciano Merli, Julia Alejandra Cricco, Hector R. Morbidoni, Guillermo R Labadie&lt;br/&gt;The emergence of drug-resistant Mycobacterium tuberculosis strains and non-tuberculous mycobacteria (NTM) species such as Mycobacterium abscessus, highlights the urgent need for new chemotypes with broad-spectrum antimycobacterial activity. In this study,...&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-06-23T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Alejandro I. Recio-Balsells</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Gabriel Di Gresia</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Marcelo Luciano Merli</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Julia Alejandra Cricco</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Hector R. Morbidoni</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Guillermo R Labadie</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00270F"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00270F</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00270F</link><title>Discovery of Novel Indazole Derivatives with Antineuroinflammatory Activity</title><description>&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Accepted Manuscript&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00270F, Research Article&lt;/div&gt;&lt;div&gt;Qing qing Zhang, Xixi Hou, Xuanwei  Zhang, Yimian Wang, Yaquan Cao, Lan Wang, Longfei Mao&lt;br/&gt;This study focuses on the critical role of microglia-mediated neuroinflammation in various neurological disorders. Utilizing the indazole heterocycle-a scaffold known for its structural plasticity and multi-target potential-as the core structure,...&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-06-23T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Qing qing Zhang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Xixi Hou</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Xuanwei  Zhang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yimian Wang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yaquan Cao</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Lan Wang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Longfei Mao</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00249H"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00249H</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00249H</link><title>Discovery of Novel SIRT3 Inhibitors with MLLr Leukemia Inhibitory Potency</title><description>&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Accepted Manuscript&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00249H, Research Article&lt;/div&gt;&lt;div&gt;Shaopeng  Chen, Xinyang Wei, Honggang Li, Jiangying Cao, lei zhang&lt;br/&gt;SIRT3 has emerged as a therapeutic target for the treatment of leukemia. Based on our previously identified lead compound, structural modification was performed in the current study. A total of...&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-06-23T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Shaopeng  Chen</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Xinyang Wei</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Honggang Li</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Jiangying Cao</creator><creator xmlns="http://purl.org/dc/elements/1.1/">lei zhang</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00085A"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00085A</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00085A</link><title>Synthesis and Bioevaluation of Substituted 2,11-dihydroimidazo[1′,5′:1,2]pyrido-[3,4-b]indoles as antiplasmodial and antiproliferative agents</title><description>&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Accepted Manuscript&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00085A, Research Article&lt;/div&gt;&lt;div&gt;Adilakshmi Vutla, Akash  Pandey, Amanullah  Sayeed, Richa  Shukla, Ashan Manhas, Niti  Kumar, Sanjeev Meena, Dipak Datta, Sanjay Batra&lt;br/&gt;The synthesis and bioevaluation of a new series of substituted 2,11-dihydroimidazo[1’,5’:1,2]pyrido-[3.4-b]indoles as antiplasmodial and antiproliferative agents are described. Several compounds (16aaf, 16abf, 16acf, 16adq, 16aeo, and 16afe ) exhibited significant...&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-06-23T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Adilakshmi Vutla</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Akash  Pandey</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Amanullah  Sayeed</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Richa  Shukla</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Ashan Manhas</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Niti  Kumar</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Sanjeev Meena</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Dipak Datta</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Sanjay Batra</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00016A"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00016A</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00016A</link><title>1,8-Naphthalimide Heterocycles as Skeleton Structures Targeting Cancer: Insights into Synthesis, Bioactivity, SAR, and Future Directions</title><description>&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Accepted Manuscript&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00016A, Review Article&lt;/div&gt;&lt;div&gt;Jitendra Choudhary, Gurdeep Kaur, Iqubal Singh&lt;br/&gt;1,8-Naphthalimide-based heterocyclic compounds have emerged as an important class of anticancer agents owing to their strong DNA-intercalating ability, topoisomerase inhibition, and capacity to modulate multiple cellular pathways. This review aims...&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-06-23T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Jitendra Choudhary</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Gurdeep Kaur</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Iqubal Singh</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00193A"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00193A</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00193A</link><title>Design, synthesis, and in silico and in vitro evaluation of novel complex naphthalimide–ciprofloxacin hybrids as next-generation antimicrobial agents</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00193A" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00193A, Research Article&lt;/div&gt;&lt;div&gt;Dharmendra Singh, Ankita Singh, Harikesh Kumar Gupta, Sajida Banoo, Sumit Maurya, Vishwakarma Krishna Ramesh, Khushbu Khushbu, Ambrish Kumar, Jyoti Kumari, Avisek Mahapa, Shruti Trivedi, Rajnish Kumar, Shashikala Verma, Arunava Manna&lt;br/&gt;A series of ciprofloxacin–naphthalimide hybrid drugs as novel antibacterial agents were synthesized and screened for their intriguing antibacterial properties.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-05-26T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Dharmendra Singh</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Ankita Singh</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Harikesh Kumar Gupta</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Sajida Banoo</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Sumit Maurya</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Vishwakarma Krishna Ramesh</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Khushbu Khushbu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Ambrish Kumar</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Jyoti Kumari</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Avisek Mahapa</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Shruti Trivedi</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Rajnish Kumar</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Shashikala Verma</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Arunava Manna</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00300A"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00300A</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00300A</link><title>Triarylphosphonium-conjugated Sn(IV)-porphyrins for antimicrobial photodynamic therapy: impact of substituents on lipophilicity, aggregation, and photoantibacterial activity</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00300A" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,3115-3123&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00300A, Research Article&lt;/div&gt;&lt;div&gt;&lt;img  alt='Open Access' src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png' /&gt; Open Access&lt;/div&gt;&lt;div&gt;&lt;a rel='license' href='http://creativecommons.org/licenses/by-nc/3.0/' target='_blank' title='This link will open in a new browser window'&gt; &lt;img src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY-NC.png' alt='Creative Commons Licence' border='none'/&gt;&lt;/a&gt;&amp;nbsp This article is licensed under a &lt;a text-decoration=none rel='license' href='http://creativecommons.org/licenses/by-nc/3.0/' target='_blank' title='This link will open in a new browser window' &gt;Creative Commons Attribution-NonCommercial 3.0 Unported Licence.&lt;/a&gt;&lt;/div&gt;&lt;div&gt;Gayathri MP, Nandhakumar Muruganandam, Sutharsan Govindarajan, Balaji Babu&lt;br/&gt;Antimicrobial photodynamic therapy is an effective approach to counteract bacterial infections that are not possible to be treated through antibiotics.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-05-19T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Gayathri MP</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Nandhakumar Muruganandam</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Sutharsan Govindarajan</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Balaji Babu</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00211K"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00211K</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00211K</link><title>Identification and structure–activity relationship analysis of minimal fusion inhibitors targeting measles virus F protein</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00211K" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,3100-3114&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00211K, Research Article&lt;/div&gt;&lt;div&gt;&lt;img  alt='Open Access' src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png' /&gt; Open Access&lt;/div&gt;&lt;div&gt;&lt;a rel='license' href='http://creativecommons.org/licenses/by-nc/3.0/' target='_blank' title='This link will open in a new browser window'&gt; &lt;img src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY-NC.png' alt='Creative Commons Licence' border='none'/&gt;&lt;/a&gt;&amp;nbsp This article is licensed under a &lt;a text-decoration=none rel='license' href='http://creativecommons.org/licenses/by-nc/3.0/' target='_blank' title='This link will open in a new browser window' &gt;Creative Commons Attribution-NonCommercial 3.0 Unported Licence.&lt;/a&gt;&lt;/div&gt;&lt;div&gt;Kazuya Kobayashi, Yuki Yamaguchi, Mizuki Itahara, Kazushige Hirata, Keisuke Aoki, Naoya Iwamoto, Hironori Hayashi, Eiichi Kodama, Shinya Oishi&lt;br/&gt;Optimization of a measles virus HR2-derived fusion inhibitor yielded a short peptide with potent antiviral activity and revealed key residues governing interactions with HR1.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-05-13T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Kazuya Kobayashi</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yuki Yamaguchi</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mizuki Itahara</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Kazushige Hirata</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Keisuke Aoki</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Naoya Iwamoto</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Hironori Hayashi</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Eiichi Kodama</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Shinya Oishi</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00226A"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00226A</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00226A</link><title>Investigation of 2,3-diaryl-1,3-thiazolidin-4-ones as promising agents for reducing lipid accumulation in liver cells through AMPK activation: synthesis, in vitro, in silico and lipidomic studies</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00226A" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,3054-3073&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00226A, Research Article&lt;/div&gt;&lt;div&gt;Arnatchai Maiuthed, Nichawadee Sandech, Meng Chieh Yang, Sucheewin Krobthong, Pattarawit Rukthong, Kittisak Sripha, Witcha Imaram, Chaiyawat Aonsri&lt;br/&gt;A series of 2,3-diaryl-1,3-thiazolidin-4-ones was synthesized and identified as promising AMP-activated protein kinase (AMPK) activators with potential lipid-lowering activity.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-05-11T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Arnatchai Maiuthed</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Nichawadee Sandech</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Meng Chieh Yang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Sucheewin Krobthong</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Pattarawit Rukthong</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Kittisak Sripha</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Witcha Imaram</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Chaiyawat Aonsri</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00154H"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00154H</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00154H</link><title>Ruthenium(II) polypyridyl complexes and the DNA damage response: mechanisms and therapeutic implications</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00154H" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,2726-2742&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00154H, Review Article&lt;/div&gt;&lt;div&gt;&lt;img  alt='Open Access' src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png' /&gt; Open Access&lt;/div&gt;&lt;div&gt;&lt;a rel='license' href='http://creativecommons.org/licenses/by/3.0/' target='_blank' title='This link will open in a new browser window'&gt; &lt;img src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY.png' alt='Creative Commons Licence' border='none' /&gt;&lt;/a&gt;&amp;nbsp This article is licensed under a &lt;a text-decoration=none rel='license' href='http://creativecommons.org/licenses/by/3.0/' target='_blank' title='This link will open in a new browser window' &gt;Creative Commons Attribution 3.0 Unported Licence.&lt;/a&gt;&lt;/div&gt;&lt;div&gt;Martin R. Gill&lt;br/&gt;This review summarises the design of ruthenium(&lt;small&gt;II&lt;/small&gt;) polypyridyl complexes (RPCs) as pharmacological DNA-targeting agents, linking binding mode, DDR pathway activation, and cancer cell fate.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-05-06T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Martin R. Gill</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00290K"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00290K</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00290K</link><title>Design, synthesis, and biological evaluation of novel SN38–sulfonamide conjugates as Topo I/CA IX dual inhibitors inducing ferroptosis in colorectal cancer</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00290K" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,3012-3025&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00290K, Research Article&lt;/div&gt;&lt;div&gt;Xinyu Zhao, Anna Ye, Yujie Wang, Yeying Qiu, Shiyan Liu, Liyu Wei, Feng Qin, Ye Zhang, Rizhen Huang&lt;br/&gt;A series of novel SN38–sulfonamide conjugates were designed and synthesized as carbonic anhydrase IX (CA IX) and topoisomerase I (Topo I) dual inhibitors for colorectal cancer therapy.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-05-04T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Xinyu Zhao</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Anna Ye</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yujie Wang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yeying Qiu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Shiyan Liu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Liyu Wei</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Feng Qin</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Ye Zhang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Rizhen Huang</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00096G"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00096G</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00096G</link><title>Light-controlled inhibition of Gram-positive bacteria by photoswitchable amphiphilic lipids (PALs)</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00096G" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,3042-3053&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00096G, Research Article&lt;/div&gt;&lt;div&gt;&lt;img  alt='Open Access' src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png' /&gt; Open Access&lt;/div&gt;&lt;div&gt;&lt;a rel='license' href='http://creativecommons.org/licenses/by/3.0/' target='_blank' title='This link will open in a new browser window'&gt; &lt;img src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY.png' alt='Creative Commons Licence' border='none' /&gt;&lt;/a&gt;&amp;nbsp This article is licensed under a &lt;a text-decoration=none rel='license' href='http://creativecommons.org/licenses/by/3.0/' target='_blank' title='This link will open in a new browser window' &gt;Creative Commons Attribution 3.0 Unported Licence.&lt;/a&gt;&lt;/div&gt;&lt;div&gt;Guilherme F. S. Fernandes, Seong-Heun Kim, Charlotte K. Hind, Jessica Furner-Pardoe, Janis Romanopulos, Christian D. Lorenz, A. James Mason, J. Mark Sutton, Daniele Castagnolo&lt;br/&gt;Photoswitchable amphiphilic lipids (PALs) enable reversible light-controlled inhibition of Gram-positive bacteria. Azobenzene photoisomerization modulates membrane insertion, switching antibacterial activity on or off depending on alkyl chain length.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-05-01T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Guilherme F. S. Fernandes</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Seong-Heun Kim</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Charlotte K. Hind</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Jessica Furner-Pardoe</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Janis Romanopulos</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Christian D. Lorenz</creator><creator xmlns="http://purl.org/dc/elements/1.1/">A. James Mason</creator><creator xmlns="http://purl.org/dc/elements/1.1/">J. Mark Sutton</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Daniele Castagnolo</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00179C"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00179C</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00179C</link><title>Development of novel chalcone-based quinazoline derivatives as dual VEGFR-2 and EGFR inhibitors</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00179C" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,2984-3002&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00179C, Research Article&lt;/div&gt;&lt;div&gt;Zainab M. Elsayed, Haytham O. Tawfik, Loah R. Hemeda, Mohamed S. Nafie, Hadia Almahli, Rehan Monir, Ikhlas A. Sindi, Eslam B. Elkaeed, Mostafa M. Elbadawi, Mahmoud A. El Hassab, Wagdy M. Eldehna&lt;br/&gt;As possible dual VEGFR-2/EGFR inhibitors, a new set of quinazoline-chalcone hybrid compounds (&lt;strong&gt;8a–h&lt;/strong&gt; and &lt;strong&gt;11a–h&lt;/strong&gt;) was logically developed and synthesized.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-05-01T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Zainab M. Elsayed</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Haytham O. Tawfik</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Loah R. Hemeda</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mohamed S. Nafie</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Hadia Almahli</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Rehan Monir</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Ikhlas A. Sindi</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Eslam B. Elkaeed</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mostafa M. Elbadawi</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mahmoud A. El Hassab</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Wagdy M. Eldehna</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00069J"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00069J</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00069J</link><title>Small-molecule therapeutics for diabetic retinopathy: from VEGFR inhibitors to emerging non-VEGF targets</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00069J" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,2860-2885&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00069J, Review Article&lt;/div&gt;&lt;div&gt;Yan Li, Wenfang Zhang, Yinliang Bai, Honghua Zhang&lt;br/&gt;Small-molecule therapy for diabetic retinopathy is advancing from VEGFR inhibitors to non-VEGF targets, with success increasingly determined by ocular PK/PD optimization, route-specific delivery, and scaffold design rather than potency alone.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-05-01T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Yan Li</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Wenfang Zhang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yinliang Bai</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Honghua Zhang</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00742A"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00742A</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00742A</link><title>Structure-guided optimisation of fenofibrate-derived oxidative phosphorylation inhibitors to modify tumour hypoxia</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD00742A" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,2925-2935&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD00742A, Research Article&lt;/div&gt;&lt;div&gt;&lt;img  alt='Open Access' src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png' /&gt; Open Access&lt;/div&gt;&lt;div&gt;&lt;a rel='license' href='http://creativecommons.org/licenses/by/3.0/' target='_blank' title='This link will open in a new browser window'&gt; &lt;img src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY.png' alt='Creative Commons Licence' border='none' /&gt;&lt;/a&gt;&amp;nbsp This article is licensed under a &lt;a text-decoration=none rel='license' href='http://creativecommons.org/licenses/by/3.0/' target='_blank' title='This link will open in a new browser window' &gt;Creative Commons Attribution 3.0 Unported Licence.&lt;/a&gt;&lt;/div&gt;&lt;div&gt;James P. Holt-Martyn, Nicole Machado, James T. T. Coates, Rathi Puliyadi, Thomas Ashton, Elysia Traynor, Samina Aslam, Thomas K. Wise, Gonzalo Rodriguez-Berriguete, Christopher J. Schofield, Geoff S. Higgins&lt;br/&gt;Hypoxia, or low levels of oxygen, is a common feature of solid tumours that makes them resistant to cancer therapies. Electron transport chain inhibitors are a promising strategy for O&lt;small&gt;&lt;sub&gt;2&lt;/sub&gt;&lt;/small&gt; redistribution to target tumour hypoxia during radiotherapy.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-04-28T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">James P. Holt-Martyn</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Nicole Machado</creator><creator xmlns="http://purl.org/dc/elements/1.1/">James T. T. Coates</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Rathi Puliyadi</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Thomas Ashton</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Elysia Traynor</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Samina Aslam</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Thomas K. Wise</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Gonzalo Rodriguez-Berriguete</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Christopher J. Schofield</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Geoff S. Higgins</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01089F"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01089F</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01089F</link><title>Sulfone and sulfoxide-containing pharmaceuticals: targets, pharmacological properties and SAR studies</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD01089F" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,2743-2767&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD01089F, Review Article&lt;/div&gt;&lt;div&gt;Yiran Zhou, Jinqu Li, Yiou Mei, Yuzhu Chen, Fengxia Sun, Yunfei Du&lt;br/&gt;Numerous sulfone/sulfoxide-containing drugs are FDA-approved for clinical use, and these moieties remain of great interest. This review overviews these agents, focusing on their targets, activities, and SAR studies.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-04-28T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Yiran Zhou</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Jinqu Li</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yiou Mei</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yuzhu Chen</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Fengxia Sun</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yunfei Du</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00185H"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00185H</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00185H</link><title>New terpenyl–cinnamoyl–hydrazone analogues of cannabidiol with potent antinociceptive effect</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00185H" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,2936-2944&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00185H, Research Article&lt;/div&gt;&lt;div&gt;João Pedro Barros de Paiva, Anna Carolina Pereira Lontra, Rachel Marins Campos, Eduardo Araújo, Thais Biondino Sardella Giorno, Mikaela Lucinda de Souza, Graziella dos Reis Rosa Franco, Claudio Viegas, Patrícia Dias Fernandes&lt;br/&gt;In this study, novel terpenyl–cinnamoyl–hydrazone analogs were synthesized and evaluated for antinociceptive potential in preclinical nociception models.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-04-24T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">João Pedro Barros de Paiva</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Anna Carolina Pereira Lontra</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Rachel Marins Campos</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Eduardo Araújo</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Thais Biondino Sardella Giorno</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mikaela Lucinda de Souza</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Graziella dos Reis Rosa Franco</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Claudio Viegas</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Patrícia Dias Fernandes</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00120C"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00120C</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00120C</link><title>Addressing multidrug-resistant bacterial infections with iridium-based theragnostic agents</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00120C" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,3003-3011&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00120C, Research Article&lt;/div&gt;&lt;div&gt;Rama Karn, Mahesmita Sahoo, Sayantani Biswas, Suravi Chauhan, Ajay Kumar Nag, Soham Basu, Srikanta Patra, Debasis Manna&lt;br/&gt;An amphiphilic iridium(&lt;small&gt;III&lt;/small&gt;) complex self-assembles into cationic nanoaggregates that disrupt bacterial membranes and facilitate selective fluorescence imaging, providing a promising theragnostic platform to combat antimicrobial resistance.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-04-24T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Rama Karn</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mahesmita Sahoo</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Sayantani Biswas</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Suravi Chauhan</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Ajay Kumar Nag</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Soham Basu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Srikanta Patra</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Debasis Manna</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00025H"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00025H</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00025H</link><title>Design, synthesis and pharmacological evaluation of 3H-spiro[benzofuran-2,4′-piperidine] IRAK4 inhibitors for the treatment of diffuse large B-cell lymphoma</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00025H" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,2907-2924&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00025H, Research Article&lt;/div&gt;&lt;div&gt;Zhiwei Chen, Qi Zhang, Yun Chen, Yi Ning, Q-i Zhang, Mengxiao Zhang, Qiupei Liu, Yi Xue, Linjiang Tong, Jian Ding, Hua Xie, Wenhu Duan&lt;br/&gt;We report the discovery of a new series of 3&lt;em&gt;H&lt;/em&gt;-spiro[benzofuran-2,4′-piperidine] IRAK4 inhibitors as potential anti-DLBCL agents.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-04-24T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Zhiwei Chen</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Qi Zhang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yun Chen</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yi Ning</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Q-i Zhang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mengxiao Zhang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Qiupei Liu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yi Xue</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Linjiang Tong</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Jian Ding</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Hua Xie</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Wenhu Duan</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00243A"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00243A</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00243A</link><title>Emerging cellular uptake mechanisms of bRo5 PROTACs</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00243A" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,2850-2859&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00243A, Review Article&lt;/div&gt;&lt;div&gt;Toshihiko Tashima&lt;br/&gt;CD36-mediated endocytosis provides an alternative uptake pathway for bRo5 PROTACs beyond passive diffusion.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-04-23T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Toshihiko Tashima</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00132G"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00132G</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00132G</link><title>Regioselective triclocarban-catalyzed synthesis of spiroindeno- and spirooxindolo-pyrrolizidines with apoptosis induction in MCF-7 cells</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00132G" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,3026-3041&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00132G, Research Article&lt;/div&gt;&lt;div&gt;V. Rukyanaik, Samata Pradhan, Chandraiah Godugu, Srinu Tothadi, Kadiyam Rama Krishna, Ravinder Pawar, Srinivas Basavoju&lt;br/&gt;The design of new molecules from known structural motifs &lt;em&gt;via&lt;/em&gt; [3 + 2] cycloaddition is a widely used strategy in modern drug discovery.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-04-22T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">V. Rukyanaik</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Samata Pradhan</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Chandraiah Godugu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Srinu Tothadi</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Kadiyam Rama Krishna</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Ravinder Pawar</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Srinivas Basavoju</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00194G"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00194G</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00194G</link><title>A new class of indole-based HDAC8 inhibitors as potential anti-lung cancer agents: in silico design, synthesis, biological assessment and binding interaction analysis</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00194G" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,2945-2962&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00194G, Research Article&lt;/div&gt;&lt;div&gt;Samima Khatun, Venkatesh Muthukumar, Ambati Himaja, Indrasis Dasgupta, Kalpataru Das, Balaram Ghosh, Shovanlal Gayen&lt;br/&gt;A novel series of indole-based hydroxamic acids was designed, synthesized, and evaluated as promising HDAC8 inhibitors for lung cancer therapy.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-04-22T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Samima Khatun</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Venkatesh Muthukumar</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Ambati Himaja</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Indrasis Dasgupta</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Kalpataru Das</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Balaram Ghosh</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Shovanlal Gayen</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00221H"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00221H</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00221H</link><title>Synthesis-guided design and discovery of alkylated indoles with antibacterial activity against MRSA</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00221H" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,3074-3099&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00221H, Research Article&lt;/div&gt;&lt;div&gt;Auqib Rashid, Vishwani Jamwal, Bilal A. Bhat, Kuljit Singh, Showkat Rashid&lt;br/&gt;This research work presents a framework for rational design, synthesis, and detailed biological evaluation of a series of C-3 alkylated indole derivatives as potential antibacterial agents against methicillin-resistant &lt;em&gt;Staphylococcus aureus&lt;/em&gt; (MRSA).&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-04-21T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Auqib Rashid</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Vishwani Jamwal</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Bilal A. Bhat</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Kuljit Singh</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Showkat Rashid</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00023A"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00023A</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00023A</link><title>Recent advances in the development of acridine-based hybrids with antiproliferative activity</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00023A" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,2768-2849&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00023A, Review Article&lt;/div&gt;&lt;div&gt;Mahdi Gallala, Najeh Tka, Sonia Aroui&lt;br/&gt;Exploring the evolution of acridine hybrids as multi-targeted anticancer agents, this review synthesizes key SAR insights and design principles. It evaluates the impact of hybridization on potency, selectivity, and preclinical development.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-04-14T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Mahdi Gallala</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Najeh Tka</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Sonia Aroui</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00076B"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00076B</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00076B</link><title>A comprehensive study of novel pregnenolone-isoxazole hybrids as selective inducers of mitochondrial apoptosis in breast cancer cells</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00076B" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,2963-2983&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00076B, Research Article&lt;/div&gt;&lt;div&gt;Victoria Malakhova, Alexander Scherbakov, Diana Salnikova, Alvina Khamidullina, Danila Sorokin, Dmitry Vasilenko, Elena Chernoburova, Elena Averina, Igor Zavarzin, Yulia Volkova&lt;br/&gt;The lead compound induced mitochondria-dependent apoptosis and demonstrated IC&lt;small&gt;&lt;sub&gt;50&lt;/sub&gt;&lt;/small&gt; values of 2.6 μM or lower against MCF7, MCF7/HT2, MDA-MB-231, and HCC1954 breast cancer cell lines under both normoxic and hypoxic conditions.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-04-08T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Victoria Malakhova</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Alexander Scherbakov</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Diana Salnikova</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Alvina Khamidullina</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Danila Sorokin</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Dmitry Vasilenko</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Elena Chernoburova</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Elena Averina</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Igor Zavarzin</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yulia Volkova</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01078K"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01078K</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01078K</link><title>Bisarylthiourea comprising cycloalkyl-thiophene-3-carboxylate derivatives as potential human toll-like receptor (TLR2) agonists: design, synthesis, and structure–activity relationship enabling the switch from TLR2/1 to TLR2/6 activation</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD01078K" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,2886-2906&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD01078K, Research Article&lt;/div&gt;&lt;div&gt;Munugala Chandrakanth, Yoshikazu Honda-Okubo, Arya C. G., Deepak B. Salunke, Nikolai Petrovsky, Janardhan Banothu&lt;br/&gt;A series of bisarylthiourea (BAT) comprising cycloalkyl-thiophene-3-carboxylate derivatives was rationally designed, synthesized, and evaluated as potential human TLR2 agonists.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-02-25T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Munugala Chandrakanth</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yoshikazu Honda-Okubo</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Arya C. G.</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Deepak B. Salunke</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Nikolai Petrovsky</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Janardhan Banothu</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01148E"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01148E</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01148E</link><title>Design and synthesis of N-3-substituted quinazolinone derivatives as anticancer agents targeting EGFR</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD01148E" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD01148E, Research Article&lt;/div&gt;&lt;div&gt;Pritam Maity, Poonam Yadav, Joydeep Chatterjee, Madhurendra Kumar Katiyar, Umashanker Navik, Raj Kumar&lt;br/&gt;A series of new &lt;em&gt;N&lt;/em&gt;-3-substituted quinazolinones targeting epidermal growth factor receptor (EGFR) was designed and synthesized for anticancer evaluation.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-06-22T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Pritam Maity</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Poonam Yadav</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Joydeep Chatterjee</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Madhurendra Kumar Katiyar</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Umashanker Navik</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Raj Kumar</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00285D"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00285D</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00285D</link><title>3-Hydroxypyrimidine-2,4-dione derivatives as monkeypox virus resolvase (Mpr) inhibitors</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00285D" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00285D, Research Article&lt;/div&gt;&lt;div&gt;Muhammad Syafiq Bin Shahari, Jacob P. Mahoney, Ziyue Wang, Anil Pant, Ajit Jagtap, Roshan Katekar, Jiashu Xie, Zhilong Yang, Zhengqiang Wang&lt;br/&gt;New HPD analogs potently inhibited purified Mpr in the low nM to sub μM range, but produced modest Gluc reduction due to poor permeability.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-06-01T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Muhammad Syafiq Bin Shahari</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Jacob P. Mahoney</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Ziyue Wang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Anil Pant</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Ajit Jagtap</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Roshan Katekar</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Jiashu Xie</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Zhilong Yang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Zhengqiang Wang</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00273K"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00273K</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00273K</link><title>Structure–activity relationship for calanthoside, a potential hair-growth stimulant with an indole 2-S-,3-O-bis-glucoside structure. Part 1: role of two glucoside moieties in promoting HFDPC proliferation</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00273K" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00273K, Research Article&lt;/div&gt;&lt;div&gt;&lt;img  alt='Open Access' src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png' /&gt; Open Access&lt;/div&gt;&lt;div&gt;&lt;a rel='license' href='http://creativecommons.org/licenses/by/3.0/' target='_blank' title='This link will open in a new browser window'&gt; &lt;img src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY.png' alt='Creative Commons Licence' border='none' /&gt;&lt;/a&gt;&amp;nbsp This article is licensed under a &lt;a text-decoration=none rel='license' href='http://creativecommons.org/licenses/by/3.0/' target='_blank' title='This link will open in a new browser window' &gt;Creative Commons Attribution 3.0 Unported Licence.&lt;/a&gt;&lt;/div&gt;&lt;div&gt;Riko Suzuki, Katsuki Takashima, Yoshiaki Manse, Haruto Nishikawa, Mina Ashidate, Shinsuke Marumoto, Fumihiro Ishikawa, Toshio Morikawa, Genzoh Tanabe&lt;br/&gt;The development of new and effective drugs for treating androgenetic alopecia (AGA) remains challenging.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-05-15T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Riko Suzuki</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Katsuki Takashima</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yoshiaki Manse</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Haruto Nishikawa</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mina Ashidate</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Shinsuke Marumoto</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Fumihiro Ishikawa</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Toshio Morikawa</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Genzoh Tanabe</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00293E"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00293E</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00293E</link><title>Research process of iminosugars in glycosidase inhibition and hypoglycemic activity</title><description>&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Accepted Manuscript&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00293E, Review Article&lt;/div&gt;&lt;div&gt;Chao-Na An, Mei-Qi  Yang, Xin-Ran  Song, Hai-Shan  Zhao, Fangqian Yin, Meng-Yue  Li, Ke-Rang Wang&lt;br/&gt;Multivalent effect or glycocluster effect is a natural phenomenon, especially for the carbohydrate-protein interactions.Multivalent glycoclusters have been widely studied, which show significantly stronger binding interactions with proteins compared with the...&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-06-18T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Chao-Na An</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mei-Qi  Yang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Xin-Ran  Song</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Hai-Shan  Zhao</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Fangqian Yin</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Meng-Yue  Li</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Ke-Rang Wang</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00029K"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00029K</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00029K</link><title>Polypharmacology in multi-drug-resistant tuberculosis: current scenario and future promise</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00029K" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00029K, Review Article&lt;/div&gt;&lt;div&gt;Itibaw Farooq, Hadiya Amin Kantroo, Mohammad Iqbal Banday, Zahoor Ahmad&lt;br/&gt;This review provides a consolidated overview of the polypharmacological strategies against MDR-TB, covering the design approaches, current progress, promising molecules, and unresolved gaps.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-06-17T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Itibaw Farooq</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Hadiya Amin Kantroo</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mohammad Iqbal Banday</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Zahoor Ahmad</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00363J"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00363J</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00363J</link><title>Rational design of an environment-sensitive fluorescent probe for monitoring butyrylcholinesterase activity and its application in Alzheimer's disease</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00363J" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00363J, Research Article&lt;/div&gt;&lt;div&gt;Ning Guo, Feng Wang, Yu Wang, Jiahao Du, Qingwen Zhang, Wenting Cao, Jiongtao Su, Fenqin Zhao, Junfeng Wang, Xiaobin Pang, Yuemin Zhou, Lin Yan&lt;br/&gt;&lt;strong&gt;LY36&lt;/strong&gt; integrates selective BChE inhibition with environment-sensitive fluorescence for real-time visualization of Alzheimer's pathology in biological models.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-06-17T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Ning Guo</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Feng Wang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yu Wang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Jiahao Du</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Qingwen Zhang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Wenting Cao</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Jiongtao Su</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Fenqin Zhao</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Junfeng Wang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Xiaobin Pang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yuemin Zhou</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Lin Yan</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00204H"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00204H</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00204H</link><title>Bismuth drug as an antibiotic adjuvant to inhibit biofilm formation via a dual mechanism</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00204H" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00204H, Research Article&lt;/div&gt;&lt;div&gt;Jingru Li, Peng Gao, Richard Yi-Tsun Kao, Hongyan Li, Hongzhe Sun&lt;br/&gt;Bismuth targets terminal oxidases CyoC and CydA, impairing energy production and elevating NO. This triggers c-di-GMP degradation and upregulates &lt;em&gt;rpoS via&lt;/em&gt; reduced cAMP–CRP, synergistically inhibiting &lt;em&gt;B. cepacia&lt;/em&gt; biofilm formation.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-05-28T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Jingru Li</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Peng Gao</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Richard Yi-Tsun Kao</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Hongyan Li</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Hongzhe Sun</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00265J"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00265J</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00265J</link><title>Novel hydroxytyrosol esters as potential anti-amyloid and neuroprotective agents for Alzheimer's disease</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00265J" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00265J, Research Article&lt;/div&gt;&lt;div&gt;&lt;img  alt='Open Access' src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png' /&gt; Open Access&lt;/div&gt;&lt;div&gt;&lt;a rel='license' href='http://creativecommons.org/licenses/by/3.0/' target='_blank' title='This link will open in a new browser window'&gt; &lt;img src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY.png' alt='Creative Commons Licence' border='none' /&gt;&lt;/a&gt;&amp;nbsp This article is licensed under a &lt;a text-decoration=none rel='license' href='http://creativecommons.org/licenses/by/3.0/' target='_blank' title='This link will open in a new browser window' &gt;Creative Commons Attribution 3.0 Unported Licence.&lt;/a&gt;&lt;/div&gt;&lt;div&gt;Ioanna Kalpaktsi, Anthi Panara, Barbara Mavroidi, Giorgos Garcia Niforos, Amalia D. Kalampaliki, Ioanna C. Vlachogianni, Eleftheria A. Georgiou, Elizabeth Fragopoulou, Anthony Tsarbopoulos, Alexios-Leandros Skaltsounis, Maria Pelecanou, Kontantinos Palikaras, Evagelos Gikas, Ioannis K. Kostakis&lt;br/&gt;Hydroxytyrosol-derived esters emerge as stable oleuropein mimetics that inhibit Aβ aggregation and confer &lt;em&gt;in vivo&lt;/em&gt; neuroprotection.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-06-04T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Ioanna Kalpaktsi</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Anthi Panara</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Barbara Mavroidi</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Giorgos Garcia Niforos</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Amalia D. Kalampaliki</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Ioanna C. Vlachogianni</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Eleftheria A. Georgiou</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Elizabeth Fragopoulou</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Anthony Tsarbopoulos</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Alexios-Leandros Skaltsounis</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Maria Pelecanou</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Kontantinos Palikaras</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Evagelos Gikas</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Ioannis K. Kostakis</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00988J"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00988J</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00988J</link><title>From AlphaFold to site-selective inhibition of DNA methylation in glioblastoma multiforme</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD00988J" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD00988J, Research Article&lt;/div&gt;&lt;div&gt;Jean-Maxime Besson, Alain Chavanieu, Arulraj Nadaradjane, Pierre-François Cartron, Marie Lopez&lt;br/&gt;Targeting specific protein–protein interactions, particularly those involving DNA methyltransferases (DNMTs), offers a promising strategy to resensitise glioblastoma multiforme cells to temozolomide.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-06-11T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Jean-Maxime Besson</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Alain Chavanieu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Arulraj Nadaradjane</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Pierre-François Cartron</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Marie Lopez</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00094K"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00094K</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00094K</link><title>New roxadustat amino acid drug conjugation derivatives: molecular docking, molecular dynamics simulation and in vitro assay</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00094K" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00094K, Research Article&lt;/div&gt;&lt;div&gt;Marjan Samadi, Azizollah Habibi, Leila Karami, Soroush Sardari, Ramin Ebrahimi Kiasari, Ghazaleh Ghavami, Mohammad Shahcheragh&lt;br/&gt;In this study, a series of novel amino acid drug conjugates (ADCs) of roxadustat were designed to inhibit the prolyl hydroxylase domain (PHD) enzyme.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-06-11T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Marjan Samadi</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Azizollah Habibi</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Leila Karami</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Soroush Sardari</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Ramin Ebrahimi Kiasari</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Ghazaleh Ghavami</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mohammad Shahcheragh</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00103C"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00103C</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00103C</link><title>Targeting Hexokinase 2 for Cancer Therapy: Advances, Limitations, and Emerging Opportunities in Inhibitors and Degraders</title><description>&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Accepted Manuscript&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00103C, Review Article&lt;/div&gt;&lt;div&gt;Xianglong Wang, Baohu Li, Wei-Wei Yao, Jinfei Yang&lt;br/&gt;Hexokinase 2 (HK2) is an important target in cancer metabolism because it supports both glycolytic flux and mitochondria-associated survival signaling. In recent years, multiple HK2-directed strategies have emerged, including active-site...&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-06-11T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Xianglong Wang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Baohu Li</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Wei-Wei Yao</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Jinfei Yang</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00281A"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00281A</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00281A</link><title>Discovery of a Potent Dual Target CDK8 and Cyclic C PROTAC Degrader for Treatment of Colorectal Cancer</title><description>&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Accepted Manuscript&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00281A, Research Article&lt;/div&gt;&lt;div&gt;Xingxing Zhang, Qingsong  Chen, Cencen Lei, Da Long Jin, Hao Dong Liu, Yumeng Wang, Chenyu zhao, Liping Zhi, Xinhua Liu&lt;br/&gt;CDK8 exerts important physiological functions, particularly in CRC, by forming intermediate complexes with Cyclic C, MED12, and MED13. In this work, different from the design of traditional single CDK8 protac...&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-06-10T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Xingxing Zhang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Qingsong  Chen</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Cencen Lei</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Da Long Jin</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Hao Dong Liu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yumeng Wang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Chenyu zhao</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Liping Zhi</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Xinhua Liu</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00275G"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00275G</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00275G</link><title>Novel urea- and piperazine-functionalized alepterolic acid derivatives: synthesis, anticancer activity, and mechanism of action</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00275G" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00275G, Research Article&lt;/div&gt;&lt;div&gt;Binbin Zhang, Yating Jia, Siyu Qiu, Yanchun Sun, Zixuan Tong, Peixin Wang, Lian Ma, Fengjiao Wang, Guozheng Huang, Jianguo Cao&lt;br/&gt;Urea- and piperazine-functionalized alepterolic acid derivatives significantly inhibited the growth of A549 cancer cells.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-06-03T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Binbin Zhang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yating Jia</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Siyu Qiu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yanchun Sun</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Zixuan Tong</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Peixin Wang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Lian Ma</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Fengjiao Wang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Guozheng Huang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Jianguo Cao</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00119J"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00119J</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00119J</link><title>Targeting DNA-PK: medicinal chemistry insights into small-molecule inhibitor discovery and optimisation</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00119J" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00119J, Review Article&lt;/div&gt;&lt;div&gt;&lt;img  alt='Open Access' src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png' /&gt; Open Access&lt;/div&gt;&lt;div&gt;&lt;a rel='license' href='http://creativecommons.org/licenses/by-nc/3.0/' target='_blank' title='This link will open in a new browser window'&gt; &lt;img src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY-NC.png' alt='Creative Commons Licence' border='none'/&gt;&lt;/a&gt;&amp;nbsp This article is licensed under a &lt;a text-decoration=none rel='license' href='http://creativecommons.org/licenses/by-nc/3.0/' target='_blank' title='This link will open in a new browser window' &gt;Creative Commons Attribution-NonCommercial 3.0 Unported Licence.&lt;/a&gt;&lt;/div&gt;&lt;div&gt;Elle Watson, Jack R. R. Hutchinson, Suzannah J. Harnor, Luke Gaughan, Celine Cano&lt;br/&gt;Since Wortmannin's discovery, DNA-PK inhibitors have expanded to optimised scaffolds, including chromen-4-ones (&lt;em&gt;e.g.&lt;/em&gt; NU5455) and purinones (&lt;em&gt;e.g.&lt;/em&gt; AZD7648). This review covers their synthesis and pharmacology from early hits to clinical candidates.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-06-08T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Elle Watson</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Jack R. R. Hutchinson</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Suzannah J. Harnor</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Luke Gaughan</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Celine Cano</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00223D"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00223D</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00223D</link><title>Recent advances in piperine and its derivatives as potential anticancer agents</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00223D" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00223D, Review Article&lt;/div&gt;&lt;div&gt;&lt;img  alt='Open Access' src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png' /&gt; Open Access&lt;/div&gt;&lt;div&gt;&lt;a rel='license' href='http://creativecommons.org/licenses/by-nc/3.0/' target='_blank' title='This link will open in a new browser window'&gt; &lt;img src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY-NC.png' alt='Creative Commons Licence' border='none'/&gt;&lt;/a&gt;&amp;nbsp This article is licensed under a &lt;a text-decoration=none rel='license' href='http://creativecommons.org/licenses/by-nc/3.0/' target='_blank' title='This link will open in a new browser window' &gt;Creative Commons Attribution-NonCommercial 3.0 Unported Licence.&lt;/a&gt;&lt;/div&gt;&lt;div&gt;Qi-Hua Yu, Zhiyan Liu, Jiazheng Liu, Li-Ping Bai&lt;br/&gt;This review identified piperine as a promising anticancer agent, demonstrating that the structural modification of its amide region can significantly improve the anticancer activity.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-05-21T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Qi-Hua Yu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Zhiyan Liu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Jiazheng Liu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Li-Ping Bai</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00158K"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00158K</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00158K</link><title>Synthetic routes towards antiviral agents from the houttuynoid family: structure–activity relationships and antiviral efficacy against herpes simplex virus type 1</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00158K" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00158K, Review Article&lt;/div&gt;&lt;div&gt;Adarsh Krishna T. P, Ajeesh Krishna T. P, Reshma Rajan, Laxman Kota, Prasobh K. Mohan&lt;br/&gt;This review delineates the total synthesis of houttuynoids, highlighting a diverse chemical toolkit and their structure–activity relationships (SARs) and antiviral efficacy.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-05-18T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Adarsh Krishna T. P</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Ajeesh Krishna T. P</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Reshma Rajan</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Laxman Kota</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Prasobh K. Mohan</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00230G"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00230G</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00230G</link><title>A Bakuchiol-Linked Tetrazole Exhibits Narrow-spectrum Activity Against Streptococcus pneumoniae</title><description>&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Accepted Manuscript&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00230G, Research Article&lt;/div&gt;&lt;div&gt;Neha  Sengar, Vidyadhar  Pratap, Tuhin Sarkar, Vishnu Kriplani, Astha Gupta, Sanjay Mandal, Prasad V. Bharatam, Dulal Panda, Inder Pal Singh&lt;br/&gt;Natural product-based amphiphilic phenolic terpenoid antimicrobial agents were rationally designed by integrating the meroterpenoid bakuchiol with a tetrazole moiety through a fragment-based drug design strategy. A library of 30 bakuchiol-linked...&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-06-02T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Neha  Sengar</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Vidyadhar  Pratap</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Tuhin Sarkar</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Vishnu Kriplani</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Astha Gupta</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Sanjay Mandal</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Prasad V. Bharatam</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Dulal Panda</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Inder Pal Singh</creator></item></channel></rss>